5AM Ventures @5amVentures
Dedicated to taking a diversified, hands-on investment approach to creating value in early-stage life science companies 5amventures.com San Francisco, CA and Boston, MA Joined November 2016-
Tweets534
-
Followers2K
-
Following70
-
Likes253
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer artivabio.com/artiva-biother… #AlloNK #NKcell #NKcells #autoimmunedisease #lupus
Today we announced our reacquisition of exclusive global development & commercial rights to CD388 from @JNJNews, our $240M private placement financing & our divestiture of rezafungin to Mundipharma. Listen to our webcast at 4:30pm ET today for more info: brnw.ch/21wJ95Z
We are thrilled to welcome Lori Kunkel, MD, to our Board of Directors, who has been a Scientific Advisor to Enliven since the beginning. We are excited to expand her role as we continue clinical development of ELVN-001 and ELVN-002. bit.ly/3vM30Jc
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis artivabio.com/artiva-biother… #AlloNK #NKcell #NKcells #clinicaltrials #clinicaltrial #autoimmunedisease #autoimmunity
$SKYE has uplisted to the Nasdaq Global Market, a significant step mirroring its fundamental accomplishments, fundamental life science investors, and capital raised in in the last quarters. We now look forward to reporting Phase 2 glaucoma data in Q2 and starting the Phase 2…
Excited to share positive proof of concept data from the ongoing Phase 1 clinical trial of ELVN-001 in CML. This brings us one step closer to helping people with cancer to not only live longer, but live better! For more details, read today’s press release: bit.ly/4aNukWh
We hope our work can translate into life-changing treatments for tens of thousands of pregnant individuals at risk for FNAIT annually, regardless of their alloimmunization status. Read more about our collaboration here: bit.ly/4aPxxEK
We’re pleased to announce that the first participant has been dosed in the Phase 1 #clinicaltrial of CMP-CPS-001, our first-in-class therapeutic for the potential treatment of #ureacycledisorders (UCDs). 📢 Learn more: bit.ly/4csWzeA
@5amVentures’ @debpalestrant, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium! Learn more about the event and how it is supporting the future of #biotech: science2startup.com
Today we report positive Phase Ib/IIa results for our brain-penetrant #NLRP3 inhibitor NT-0796 in #Parkinson’s disease. Reductions in pro-inflammatory and #neurodegenerative biomarkers signal its potential to change the treatment paradigm. Learn more at bit.ly/3PcPchw
Thank you to #Science2Startup’s sponsors –@Colliers, @Deloitte, @Evotec, @goodwinlaw, @Pliancy_ & @SiliconVlyBank – for making this year’s event a reality! Learn more about the symposium, the advisors & the firms supporting the future of #biotech here: science2startup.com
The 4th #Science2Startup takes place this April in Cambridge, hosted by @5amVentures @FPrimeCapital,@atlasventure @OUP_VC, @MassBio, and RA Capital Management. Learn more about this year's event, where world-class scientists connect with top investors: science2startup.com
Today we reported the completed enrollment of our Phase 2a clinical trial of SBI-100 ophthalmic emulsion in glaucoma and ocular hypertension. For additional details, read the full press release here: bit.ly/3SRzOYL #skyebioscience #glaucoma #clinicaltrials
Artiva Biotherapeutics Receives FDA Fast Track Designation for AlloNK® in #Lupus Nephritis artivabio.com/artiva-biother… #AlloNK #NKcell #NKcells #clinicaltrials #clinicaltrial #autoimmunedisease #autoimmunity
Preclinical data exploring the potential of Nodthera’s brain-penetrant #NLRP3 #inflammasome inhibitors to reverse diet-induced #obesity and disease-relevant #inflammatory #biomarkers have been published in @JPET_Journal. For more: jpet.aspetjournals.org/content/388/3/… #Publication
Today we announced receipt of an ~$11 million milestone payment from @MundipharmaTalk following European approval of our invasive candidiasis drug in adult patients. Read the press release: brnw.ch/21wGTHu
Such exciting news for the #NEVCA: 5 new board directors have been appointed, @lilylyman has assumed the role of Vice Chair, and Deb Palestrant the role of Treasurer! Read about the board developments & welcome in Jessica, Ian, Mark, Charlie, and Kadir: bit.ly/nevcaboard24
We are pleased to welcome Dr. Thomas Jaecklin to NodThera as Chief Medical Officer. An accomplished #DrugDevelopment leader, Thomas brings more than 20 years of strategic experience across large #pharma, #biotech and academic medicine. For more: nodthera.com/news/nodthera-…
#NEWS: Arvinas and @pfizer’s investigational treatment receives FDA Fast Track designation for patients with ER+/HER2- metastatic #breastcancer rb.gy/4k3n43 $ARVN $PFE
Today our treatment for adults with invasive candidiasis has been approved by the United Kingdom @MHRAgovuk. Read here for more information on this milestone: brnw.ch/21wGuRb
Devin Quinlan @devinquinlan
936 Followers 363 Following 🧬🚀 Biotech VC & company creation @MPMCapital.👨🔬Biological Engineering PhD @MIT. 🙆♂️ Fmr performer/director @improvboston. he/him. 🌶 Hot takes are my own
Sara Nayeem @SaraNayeem
11K Followers 2K Following Invest in emerging biopharma co's as EVP, Investments at Enavate Sciences. Prior NEA and Avoro Ventures. I post advice for biopharma exec's and emerging VCs.
Patrick Hsu @pdhsu
30K Followers 3K Following co-founder @ArcInstitute, @BerkeleyBioE professor | researcher & investor in genome editing, biotech, AI | 🇨🇦 @harvard @broadinstitute @editasmed, Fast Grants
Carolyn Ng @Car0lyn_Ng
3K Followers 596 Following Partner @TPG leading life sciences venture investing, oncology scientist, chill mom. Tweets completely my own
Dan Nomura @DanNomura
17K Followers 9K Following Professor of Chemical Biology and Molecular Therapeutics at UC Berkeley; Departments of Chemistry and Molecular and Cell Biology
Atlas Venture @atlasventure
13K Followers 289 Following Atlas Venture invests in early-stage life sciences innovation. We partner with remarkable entrepreneurs to build breakthrough biotech companies.
Allison DeAngelis @ADeAngelis_bio
5K Followers 891 Following Reporter covering biopharma startups and venture capital at @statnews. Formerly @thisisinsider and @bosbizjournal.
Deepak Jha @dkjhaunc
3K Followers 5K Following Drug discovery, Biotech & Pharma. AIIMS, JNU, UNC-Chapel Hill, BCH/HMS alumnus. RT≠ endorsements; Tweets mine not employer’s. A Dilliwala 🇮🇳 in Boston 🇺🇸
Nabiha Saklayen @nabsicle
3K Followers 2K Following your cells, your cure. CEO + Co-Founder @CellinoBio. @ToryBurchFdn Fellow @igisci. co-creator @iamastem. physics PhD @HarvardUniv. views my own.
Ritu Raman @DrRituRaman
23K Followers 2K Following d’Arbeloff Asst Prof @MIT • Neuromuscular Tissue Engineering for Medicine & Robotics • Women in STEM • 🇺🇸 via 🇮🇳 🇰🇪
Joseph Rea @rea1172
152 Followers 166 Following Private Equity Fund Manager & Real Estate Investor at Rea Capital
Hok Fung Chan @jChan_HF
1 Followers 16 Following
Benito F Buksh @BenitoBuksh
235 Followers 550 Following Chemical biologist @MacMillan_lab @Princeton, Runner, @UTAustin alumnus
Aditya Jain @adityajain_42
171 Followers 198 Following MD Student @harvardmed Medical AI Researcher @broadinstitute Co-Founder @samyakscience Op-Med Fellow @doximity
Jay Sanghvi @JaySanghvi_
223 Followers 294 Following MD candidate (MS4) @icahnmountsinai || Incoming Resident @NYUGSOM_SurgRes @nyuVIR
Susan Kinkead @susankinkead
77 Followers 478 Following Biotech PR/IR guru, kid wrangler, dog lover, nature-seeker, reader, traveler. Creative and caffeinated. Tweets are my own.
Alex Wong @alexmwong
232 Followers 551 Following MD-PhD Candidate @BrownMedicine | Co-Founder @FictionForKids | VC @VanWickleV @[email protected]
Pavel Shumilkin @recyclen
144 Followers 2K Following
Brian Uherek @BrianUherek
584 Followers 567 Following Job 1: Lookin' after 97 year-old Dad. Life is good. No complaints. Views my own. #biotech #endcancer
Rowan Gardner @rowan_UK
3K Followers 4K Following CBIO @precisionlifeai @cartierawards NED @DHCWales & @STFC_B2B Interests #diversity #ai #techbio #climate #precisionmedicine #digitalhealth personal account
Stephen Wilkinson @SingularStephen
0 Followers 15 Following
MSL @MinsubLee138
146 Followers 119 Following Biomedical research scientist with a strong passion for education, finances, politics, and global economics
How Finance Works? @HowFinanceWorks
363 Followers 321 Following learning about How Finance Works & sharing what I learn // advanced degree in the biomedical sciences // formerly Cashflow.R.E.A.M
Chicago Biomedical Co.. @ChiBiomed
826 Followers 609 Following Collaborative initiative of biomedical researchers at Northwestern, UChicago and UIC. Generously funded by the Searle Funds at The Chicago Community Trust.
Brando Tiseo @tixbrando
55 Followers 70 Following
R.R.G. @WeCr8revolution
898 Followers 5K Following Marketing pro with startup founding experience. Changing startups journey from cash burn to cash rich .Call link https://t.co/EMzH7qC3xa
Bernard Liu, Ph.D. @bernardliu
16 Followers 310 Following Cancer Biologist, Outdoor Enthusiast, Taiwanese-American, Dog (Toffee) dad
Allison Mead Talbot @AMeadTalbot
291 Followers 531 Following Biotech. PR. Traveling. Sailing. HOYAS. Choate. Coffee. Head of Communications @PureTechH
Priscilla S @prizcilla
137 Followers 30 Following
Patrick Malloy @mal99104
1 Followers 198 Following
roshnig @tealalps
5 Followers 63 Following
Parthiv Patel @periodicparthiv
38 Followers 174 Following Student @Penn and @Wharton | Exploring the Biopharma Industry
Test @Test1150658
75 Followers 159 Following
Shivani Sharma @shivanirsharma
1K Followers 4K Following Founder @KleapLtd @tulXsi @KleapCon @KIIS_KLEAP @0xSecureWeb3 @trXapi Chapter Leader @infosecgirls @infoseckids @InfosecDiversty Member @barriers_in @GlobalWIC
NoWei @NoWei69006987
0 Followers 290 Following
SeedBlink @seed_blink
612 Followers 2K Following Complete financing infrastructure for European tech innovation.
Fonds de solidarité .. @FondsFTQ
4K Followers 1K Following Le Fonds de solidarité FTQ est un fonds de travailleurs qui s'investit pour une meilleure société.
(((Shiloh TD))) @Shilohtd
165 Followers 975 Following Definitely a small white dog sitting in a burlap sack, Also I do a lot of research.
Rachel Krompinger @RachelKromping1
0 Followers 177 Following
Amy Simmens @A1ways_Grateful
83 Followers 2K Following
Creighton HealthTech @CreightonHealth
91 Followers 517 Following Building Momentum for #Lifesciences #Healthcare Startups | Active @HeidiCreighton | Email: [email protected] #GenerativeAI #Genomics #SpatialBiology
Cancer Research Horiz.. @CR_Horizons
2K Followers 2K Following We are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
Alexia Yun @alexia_yun_
11 Followers 64 Following currently @ChemeCU @nucleateNY @columbia_tech | prev @cal
Anthony @anthonystaj
149 Followers 1K Following biotech adventurer. I moonlight as a Jason Momoa impersonator. ramen reviewer. die hard Detroit Lions fan
Fund Shack @FundShack1
92 Followers 1K Following The private capital podcast, featuring top private equity and venture capital fund managers, investors, plus M&A, corporate finance and governance.
Gandhar Datar @Gandhar_Datar
93 Followers 265 Following MD/PhD Student @BCMHouston. Studying mutant NPM1 biology in Acute Myeloid Leukemia in @Goodell_Lab. MCB Alum ‘16 @UofIllinois. Opinions my own.
James Murray 🇺🇸 @_jcmurray
476 Followers 785 Following Investing in the future of vision care & treatment - co-founder @exsightv | lawyer turned VC | Aspiring polymath | Buffalo, NY native 🦬| NYC 🗽
AIL (e/acc)^ @edolmatsky
96 Followers 1K Following The development and proliferation of AI is a moral obligation that we have to ourselves, to our children, and to our future.
Yolaine @_Yolaine_
140 Followers 726 Following Field Application Director. Promoting great science discoveries with positive impacts #drugdevelopment #innovation #lifesciences
Ankush Sharma @Biologynerd2
177 Followers 3K Following mTor || Preclinical Studies || Oncology Models
Jon Chee @jonchee_excedr
663 Followers 424 Following CEO & Co-founder at @ExcedrInc 🔬 | Host at The Biotech Startups Podcast 🧬
Vinay Eapen🔬🧬�.. @Post_Dogg
683 Followers 1K Following Biologist ⭐️ Targeted protein degradation and beyond⭐️ @casmatx formerly @harvardmed @danafarber @brandeisu
Luke Timmerman @ldtimmerman
35K Followers 231 Following Biotech Journalist. Founder @TimmermanReport. Mountaineer. Volunteer. @LS_Cares @DamonRunyon
Atlas Venture @atlasventure
13K Followers 289 Following Atlas Venture invests in early-stage life sciences innovation. We partner with remarkable entrepreneurs to build breakthrough biotech companies.
FierceBiotech @FierceBiotech
101K Followers 649 Following The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Enliven Therapeutics @Enliven_Tx
50 Followers 237 Following Discovering and developing next generation precision oncology therapeutics
HALIO, Inc. @HalioInc
609 Followers 2K Following The world’s most advanced smart glass. Reduce glare and enhance the views while being energy efficient. https://t.co/fi0IsZbcma
Rallybio @rallybio
111 Followers 103 Following We are committed to discovering and developing life-transforming therapies for people with severe and rare diseases. Community guidelines: https://t.co/0p7mwSWuK7
Precede Biosciences @Precede_Bio
112 Followers 94 Following We're impacting precision medicine with a first-in-class liquid biopsy platform, redefining what can be learned from a simple🩸blood draw.
Skye Bioscience @skyebioscience
1K Followers 122 Following We are focused on unlocking the pharmaceutical potential of the endocannabinoid system. | OTC: $SKYE
Osage Univ. Partners @OUP_VC
1K Followers 740 Following We're a VC fund with a singular focus on university startups. @OsageVP is our sister fund.
F-Prime Capital @FPrimeCapital
3K Followers 369 Following We create and invest in healthcare and technology companies that impact lives all over the world.
Escient Pharmaceutica.. @EscientP
60 Followers 57 Following Escient strives to discover and develop novel, life changing medicines for challenging disorders where current treatments are insufficient or nonexistent
NodThera @NodThera
246 Followers 207 Following Treating chronic disease by targeting inflammation at its source
Pliancy @Pliancy_
22 Followers 89 Following We provide experience driven IT services for capital management and life sciences industries.
Dianthus Therapeutics @dianthustx
42 Followers 45 Following Unlocking the full potential of complement therapeutics through the power of selectivity.
Entrada Therapeutics @entradatx
242 Followers 109 Following Innovating to transform the treatment of devastating diseases through intracellular therapeutics. #EntradaHere Community guidelines: https://t.co/OKGDgwRdVK
Kinaset Therapeutics @KinasetT
77 Followers 72 Following Kinaset Therapeutics is a biopharma company developing novel respiratory therapeutics. Lead program KN-002 is novel anti-inflammatory for asthma.
CAMP4 Therapeutics @camp4tx
438 Followers 38 Following We are pioneering a new approach to upregulate genes by targeting regulatory RNA using programmable oligonucleotide therapeutics.
ArtivaBio @ArtivaBio
298 Followers 42 Following We are dedicated to making safe and effective cell therapies accessible to any cancer patient who may benefit. #NKcelltherapy #celltherapy #cancer #NKcells
BlueLight Therapeutic.. @BlueLightTx
25 Followers 18 Following Leveraging conformation to drug challenging targets
Xconomy @Xconomy
25K Followers 3K Following Authoritative voice on biotech's exponential economy: news, events, awards, webinars, whitepapers, #Xconomists, #XceleratingLS, #XconBioRoundup, #XconInsight
Novome Biotechnologie.. @novomebio
184 Followers 0 Following Engineering Living Medicines for Chronic Diseases
TMRW Life Sciences, I.. @TMRWLifeSci
487 Followers 720 Following TMRW Life Sciences, Inc. has created the world’s first integrated platform for automated, software-guided cryospecimen management.
Timmerman Report @timmermanreport
7K Followers 4 Following Timmerman Report is an independent biotech publication. Subscribe today! https://t.co/0HEk9RZHMV…
BioCentury @BioCentury
16K Followers 2K Following The leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://t.co/V33Z1gfUfZ
Cleave Therapeutics @CleaveTherapeu1
71 Followers 119 Following Cleave Therapeutics is a biopharmaceutical company based in San Francisco, CA. Cleave's primary focus is targeting VCP/p97 in oncology and neurodegeneration.
Vor Bio @VorBio
646 Followers 289 Following Vor Bio's vision is to cure blood cancers through cell and genome engineering.
Life Science Cares Bo.. @LS_Cares
3K Followers 850 Following Uniting the greater Boston life science community in the fight against poverty. See our affiliates @LS_CaresPhilly @LS_CaresSD @LS_CaresBayArea
DebPalestrant @debpalestrant
849 Followers 627 Following Crystallographer turned company builder, Partner at 5AM Ventures via RelayTx, Editas, Blueprint, TRV. Fan of companies that focus on patients. Tweets are mine.
Magnetic Insight @magneticinsight
565 Followers 1K Following Magnetic Insight has pioneered a new diagnostic imaging technology called magnetic particle imaging (MPI) that has the potential to transform medical imaging.
Cabaletta Bio @CabalettaBio
428 Followers 153 Following Transforming the treatment of B cell-mediated autoimmune diseases
Expansion Therapeutic.. @expansionrx
527 Followers 192 Following Bringing transformative therapies to patients with severe RNA-mediated diseases.
Kinestral @Kinestral
319 Followers 927 Following Technology for next-generation windows. Creator of Halio® the world's most advanced smart-tinting glass. #smarttintingglass @halioglass
Wildcat Discovery Tec.. @WildcatBattery
191 Followers 213 Following Producing High-Performance, U.S.-made Cathodes 🔋
Akouos Inc @AkouosInc
363 Followers 0 Following
Crinetics Pharmaceuti.. @Crinetics
878 Followers 545 Following Discovering and developing novel therapeutics for #RareEndocrine disorders. #Crinetics #RareDisease #acromegaly #CarcinoidSyndrome
Arboretum Ventures @ArboretumVC
1K Followers 105 Following Arboretum Ventures is an early-stage venture capital firm that invests in high potential private healthcare and life sciences companies.
scPharmaceuticals @scPharmaUSA
351 Followers 1K Following A pharmaceutical company focused on developing a portfolio of transformative products to enhance the potential of outpatient care.
Jason Ruth @JasonRRuth
394 Followers 276 Following Building + investing in medicine's future @5amVentures. ex-@broadinstitute. @CureCastleman.
FiercePharma @FiercePharma
98K Followers 485 Following Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.
Scientist.com @scientist_com
2K Followers 2K Following B2B marketplace that's transforming scientific research. #Scientist #FasterScience
Corey McCann @Corey_M_McCann
675 Followers 151 Following Healthcare Exec/Investor. Current T.🦖x Capital. Fmr CE🍐 of #Pear_Tx. 🦄recovering physician-neuroscientist-McK consultant. 🤵🏼fantasy football commissioner.
Impel Pharmaceuticals @ImpelPharma
431 Followers 348 Following Developing life-changing, innovative therapies for diseases with unmet needs
Nohla Therapeutics @nohlatx
203 Followers 23 Following Nohla is the leading developer of universal donor cell therapies for patients with hematologic malignances and other critical diseases.
Arvinas @ArvinasInc
3K Followers 259 Following A revolutionary approach to protein degradation therapeutics. https://t.co/eppnBxVbQi
RareCyte, Inc. @RareCyte
374 Followers 141 Following RareCyte is an innovative precision biology company enabling advances in oncology, immuno-oncology, maternal-fetal health, & cell and gene therapy.
ScottRocklage @SRocklage
94 Followers 147 Following
Hannah H. Chang @HannahHChang
159 Followers 44 Following Physician scientist, life sciences VC, former BCG consultant
SpyryxBio @SpyryxBio
133 Followers 29 Following Spyryx Biosciences is developing next generation therapeutics for severe lung diseases with a particular focus on Cystic FibrosisWe are excited to announce that two abstracts for @Precede_Bio's comprehensive epigenomic liquid biopsy platform have been selected for presentation at #ASCO24, taking place from May 31-June 4, 2024 in Chicago. #PrecisionMedicine #PrecisionOncology #Healthcare #DrugDevelopment…
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer artivabio.com/artiva-biother… #AlloNK #NKcell #NKcells #autoimmunedisease #lupus
Welcoming @skyebioscience to the @NasdaqExchange Opening Bell. x.com/i/broadcasts/1…
After uplisting to the Nasdaq Global Market last week, Skye Bioscience, Inc. will be ringing the Nasdaq bell this Thursday, April 18 at 6:30am PST/9:30am EST! Join us as we mark this exciting milestone in our journey. Stay tuned for the broadcasting link to watch live, coming…
.@tpg's Partner and Managing Director's, Shinichiro Fuse, Ph.D. will join researchers, entrepreneurs, and top investors this April for the 2024 #Science2Startup symposium! Learn more about the event and the how it is supporting the future of #biotech: science2startup.com
Thank you to #Science2Startup’s sponsors – @Colliers, @Deloitte, @Evotec, @goodwinlaw, @Pliancy_ & @SiliconVlyBank – for making this year’s event a reality! Learn more about the symposium, the advisors & the firms supporting the future of #biotech here: science2startup.com
From California: @5amVentures's Andy Schwab shares his take on biotech and his firm's portfolio, including embryo storage company @TMRWLifeSci. Full video: biotechtv.com/post/5am-ventu…
The 4th #Science2Startup takes place this April in Cambridge, hosted by @FPrimeCapital, @atlasventure @5amVentures @OUP_VC, @MassBio, and RA Capital Management. Learn more about this year's event, where world-class scientists connect with top investors: science2startup.com
We are excited to share our new publication in @JPET_Journal unveiling the pharmacokinetics and pharmacodynamics of our lead clinical asset, NT-0796, the brain penetrant #NLRP3 #inflammasome inhibitor undergoing evaluation in Parkinson’s patients. jpet.aspetjournals.org/content/early/…
We’re honored to be recognized in the 2023 #PM360InnovationsIssue for advancing the first allogeneic NK cell therapy to #clinicaltrials for the #autoimmunedisease #lupus nephritis. pm360online.com/pm360-2023-inn… #NKcells #AlloNK
After $SKYE ’s acquisition of a Phase 2-ready peripheral CB1 inhibitor, nimacimab, in August and advancing our assessment of the clinical and commercial landscape, we are announcing our plan to conduct a Phase 2 study in patients with obesity and chronic kidney disease starting…
Tullia Bruno, PhD, examined immuno-oncology challenges and trends on a @UPMCEnterprises Life Sciences Summit panel with industry leaders from @BlueSphereBio, @5amVentures, Novasenta, and Century Therapeutics. Panel Insights available here: bit.ly/3MXbMtg
Meet us at our Bay Area CEO Summit to hear keynotes from @5amVentures & @bmsnews, & sessions with panelists from @GileadSciences, @EliLillyandCo, @Merck, @HSBCInnovation, @Savills, @AbderaTx, @FrazierHealth, @BioWestlake, @wilsonsonsini, @DCVCBio, & more: bit.ly/3PSTh9Y
Precede to present our first scientific and clinical data from our liquid biopsy platform in an oral abstract at #ESMO23. Data demonstrates the significance of our approach to informing therapeutic decision-making & clinical diagnoses. #oncology #precisionmedicine @myESMO
@FPrimeCapital, @atlasventure, @5amVentures , @OUP_VC , @MassBio and RA Capital Management will host the 2024 #Science2Startup symposium on April 10th. Do you have an exciting concept for a #biotech startup? Submit your application by October 30th: science2startup.com
Are you interested in gaining experience in biotech venture creation and venture capital? Come join us to learn more about the @5amVentures Fellowship program. Presented by Katie Spielberg (Senior Associate) and Aniqa Tasnim (Associate) from the 5AM Boston office.
Today, we announced that we will be presenting new data on our drug-Fc conjugate (DFC) candidate for influenza at @idweek taking place both in-person in Boston, MA and virtually from Oct 11-15. Click here: brnw.ch/21wCZc5 #IDWeek2023
Kinaset was selected by Life Science Leader as this month’s “Company to Watch.” Read what CEO @CKinasett has to say about our lead asset, KN-002, an inhaled pan-JAK being advanced to treat #severeasthma & other #respiratorydiseases bit.ly/3JM3bIl
Explore why CAMP4 is at the forefront of regRNAs with our President & CEO, Josh Mandel-Brehm. Newly published research in Molecular Cell found that RNA binding contributes to TF function by promoting the dynamic association between DNA, RNA, & TF on chromatin. #drugdiscovery
scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes. Learn more: bit.ly/3CL3L5g
Trends for United States
You might like
